ReP USP - Resultado da busca

Artigo de periodico
Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer (2015)
Lopes-Ramos, Camila; Koyama, Fernanda C.; Habr-Gama, Angelita; Salim, Anna Christina M.; Bettoni, Fabiana; Asprino, Paula F.; França, Gustavo S.; Gama-Rodrigues, Joaquim; Parmigiani, Raphael B.; Perez, Rodrigo O.; Galante, Pedro A. F.; Camargo, Anamaria A.
Source: Cancer Genetics. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS (TERAPIA), QUIMIOTERAPIA ADJUVANTE, CO-TERAPIA, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES-RAMOS, Camila et al. Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer. Cancer Genetics, v. 208, n. 6, p. 319-326, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.cancergen.2015.03.010. Acesso em: 26 jun. 2024.
APA
Lopes-Ramos, C., Koyama, F. C., Habr-Gama, A., Salim, A. C. M., Bettoni, F., Asprino, P. F., et al. (2015). Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer. Cancer Genetics, 208( 6), 319-326. doi:10.1016/j.cancergen.2015.03.010
NLM
Lopes-Ramos C, Koyama FC, Habr-Gama A, Salim ACM, Bettoni F, Asprino PF, França GS, Gama-Rodrigues J, Parmigiani RB, Perez RO, Galante PAF, Camargo AA. Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer [Internet]. Cancer Genetics. 2015 ; 208( 6): 319-326.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.cancergen.2015.03.010
Vancouver
Lopes-Ramos C, Koyama FC, Habr-Gama A, Salim ACM, Bettoni F, Asprino PF, França GS, Gama-Rodrigues J, Parmigiani RB, Perez RO, Galante PAF, Camargo AA. Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer [Internet]. Cancer Genetics. 2015 ; 208( 6): 319-326.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.cancergen.2015.03.010
Artigo de periodico
The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation (2015)
Carpinetti, Paola; Donnard, Elisa; Bettoni, Fabiana; Asprino, Paula; Koyama, Fernanda; Rozanski, Andrei; Sabbaga, Jorge; Habr-Gama, Angelita; Parmigiani, Raphael B.; Galante, Pedro A. F.; Perez, Rodrigo O.; Camargo, Anamaria A.
Source: Oncotarget. Unidade: FM
Subjects: NEOPLASIAS RETAIS (CIRURGIA), BIÓPSIA, QUIMIOTERAPIA ADJUVANTE, MONITORIZAÇÃO FISIOLÓGICA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARPINETTI, Paola et al. The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation. Oncotarget, v. 6, n. 35, p. 38360-38371, 2015Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.5256. Acesso em: 26 jun. 2024.
APA
Carpinetti, P., Donnard, E., Bettoni, F., Asprino, P., Koyama, F., Rozanski, A., et al. (2015). The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation. Oncotarget, 6( 35), 38360-38371. doi:10.18632/oncotarget.5256
NLM
Carpinetti P, Donnard E, Bettoni F, Asprino P, Koyama F, Rozanski A, Sabbaga J, Habr-Gama A, Parmigiani RB, Galante PAF, Perez RO, Camargo AA. The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation [Internet]. Oncotarget. 2015 ; 6( 35): 38360-38371.[citado 2024 jun. 26 ] Available from: https://doi.org/10.18632/oncotarget.5256
Vancouver
Carpinetti P, Donnard E, Bettoni F, Asprino P, Koyama F, Rozanski A, Sabbaga J, Habr-Gama A, Parmigiani RB, Galante PAF, Perez RO, Camargo AA. The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation [Internet]. Oncotarget. 2015 ; 6( 35): 38360-38371.[citado 2024 jun. 26 ] Available from: https://doi.org/10.18632/oncotarget.5256
Artigo de periodico
Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients (2014)
Ramos, Camila Ramos; Habr Gama, Angelita; Quevedo, Bruna de Souza; Felício N.; Bettoni, Fabiana; Koyama, Fernanda C.; Arprino, Paula F.; Galante, Pedro A.; Gama-Rodrigues, J.; Camargo, Anamaria A.; Perez, Rodrigo O.; Parmigiani, Raphael B.
Source: BMC Medical Genomics. Unidade: FM
Subjects: NEOPLASIAS RETAIS (TERAPIA), BIÓPSIA, BIOMARCADORES, RADIOTERAPIA, CO-TERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMOS, Camila Ramos et al. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients. BMC Medical Genomics, 2014Tradução . . Disponível em: https://doi.org/10.1186/s12920-014-0068-7. Acesso em: 26 jun. 2024.
APA
Ramos, C. R., Habr Gama, A., Quevedo, B. de S., Felício N.,, Bettoni, F., Koyama, F. C., et al. (2014). Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients. BMC Medical Genomics. doi:10.1186/s12920-014-0068-7
NLM
Ramos CR, Habr Gama A, Quevedo B de S, Felício N., Bettoni F, Koyama FC, Arprino PF, Galante PA, Gama-Rodrigues J, Camargo AA, Perez RO, Parmigiani RB. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients [Internet]. BMC Medical Genomics. 2014 ;[citado 2024 jun. 26 ] Available from: https://doi.org/10.1186/s12920-014-0068-7
Vancouver
Ramos CR, Habr Gama A, Quevedo B de S, Felício N., Bettoni F, Koyama FC, Arprino PF, Galante PA, Gama-Rodrigues J, Camargo AA, Perez RO, Parmigiani RB. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients [Internet]. BMC Medical Genomics. 2014 ;[citado 2024 jun. 26 ] Available from: https://doi.org/10.1186/s12920-014-0068-7

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em